KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

A new study in Life Science Alliance reveals a key genetic connection between cancer susceptibility and tissue regeneration. Researchers at Karolinska ...

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...